CL Educate emerges healthier from FY21

FY21 didn’t turn out too bad for CL Educate. In fact, when it looks back at FY21 many years later, it may find that it was a key turning point in its corporate journey. That is not to say it was a rosy FY21 for CL. The global scourge Covid…

Read More

Chemcrux declares decent performance in FY21 despite plant closure

Chemcrux Enterprises suffered only a 7% revenue drop and 17% EBITDA drop in FY21, despite losing over 23% of productive days due to plant closure, and Covid related production constraints in FY21. Highlights of the FY21 results: FY21 full year sales came in at Rs 533m, 7% drop over sales…

Read More

WISDOM IR CASE STUDY – CL EDUCATE LIMITED

Here’s a case study showing Wisdom IR’s research based approach to investor relations works.    

Read More

Chemcrux delivers steady performance in FY21 first half despite Covid

Chemcrux Enterprise is a Specialty Chemical company listed on the BSE SME platform. Chemcrux manufactures import-substitute chemicals that go into manufacture of pharma APIs and pigments. Some of its key products are variants of Chloro Benzoic Acids and Nitro Benzoic Acid. The company’s results for first half of FY20-21 show…

Read More

USD 5.6B of investments into Lifesciences startups in September’20

We recorded 96 VC/PE transactions pertaining to the global life sciences sector for Sep 2020, aggregating to a sum of USD 5.6B. USA recorded 52 transactions for with total investment of USD 2.6B. China reported investment of USD 1.5B over 16 VC/PE transactions. China also reported 2 IPOs aggregating to…

Read More

CL Educate recovers from Covid Blues

Shares of CL Educate have done well since August 20. CL’s share price was Rs 38 at the end of July. The price rose to Rs 46.5, and is now around Rs 70. This is a smart recovery after the fall CL’s shares had suffered in March due to Covid…

Read More